UA11075A - Спосіб одержаhhя ліофілізату - Google Patents

Спосіб одержаhhя ліофілізату

Info

Publication number
UA11075A
UA11075A UA4203570A UA4203570A UA11075A UA 11075 A UA11075 A UA 11075A UA 4203570 A UA4203570 A UA 4203570A UA 4203570 A UA4203570 A UA 4203570A UA 11075 A UA11075 A UA 11075A
Authority
UA
Ukraine
Prior art keywords
lyophylisate
obtaining
preparation
lyophilizate
iphosphamide
Prior art date
Application number
UA4203570A
Other languages
English (en)
Russian (ru)
Ukrainian (uk)
Inventor
Зауербір Дітер
Петер Дамманн Уве
Ісаак Отто
Original Assignee
Аста Медіка Аг
Аста Медика Аг
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Аста Медіка Аг, Аста Медика Аг filed Critical Аста Медіка Аг
Publication of UA11075A publication Critical patent/UA11075A/uk

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/19Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles lyophilised, i.e. freeze-dried, solutions or dispersions
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/66Phosphorus compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/66Phosphorus compounds
    • A61K31/675Phosphorus compounds having nitrogen as a ring hetero atom, e.g. pyridoxal phosphate
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0019Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Cephalosporin Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Amplifiers (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Control Of El Displays (AREA)
  • Diaphragms For Electromechanical Transducers (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Indole Compounds (AREA)
UA4203570A 1986-10-31 1987-10-29 Спосіб одержаhhя ліофілізату UA11075A (uk)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE3637089 1986-10-31

Publications (1)

Publication Number Publication Date
UA11075A true UA11075A (uk) 1996-12-25

Family

ID=6312873

Family Applications (1)

Application Number Title Priority Date Filing Date
UA4203570A UA11075A (uk) 1986-10-31 1987-10-29 Спосіб одержаhhя ліофілізату

Country Status (25)

Country Link
EP (1) EP0265812B1 (cg-RX-API-DMAC7.html)
JP (1) JPS63159319A (cg-RX-API-DMAC7.html)
KR (1) KR900003491B1 (cg-RX-API-DMAC7.html)
AT (1) ATE55250T1 (cg-RX-API-DMAC7.html)
AU (1) AU598602B2 (cg-RX-API-DMAC7.html)
CA (1) CA1314231C (cg-RX-API-DMAC7.html)
DD (1) DD262582A5 (cg-RX-API-DMAC7.html)
DE (1) DE3764235D1 (cg-RX-API-DMAC7.html)
DK (1) DK169308B1 (cg-RX-API-DMAC7.html)
EG (1) EG18333A (cg-RX-API-DMAC7.html)
ES (1) ES2017982B3 (cg-RX-API-DMAC7.html)
FI (1) FI87140C (cg-RX-API-DMAC7.html)
GE (1) GEP19971025B (cg-RX-API-DMAC7.html)
GR (1) GR3000708T3 (cg-RX-API-DMAC7.html)
HU (1) HU197987B (cg-RX-API-DMAC7.html)
IL (1) IL84312A (cg-RX-API-DMAC7.html)
IN (1) IN168119B (cg-RX-API-DMAC7.html)
LV (1) LV10051B (cg-RX-API-DMAC7.html)
MX (1) MX8958A (cg-RX-API-DMAC7.html)
NO (1) NO873860L (cg-RX-API-DMAC7.html)
PT (1) PT86032B (cg-RX-API-DMAC7.html)
RU (1) RU1836079C (cg-RX-API-DMAC7.html)
UA (1) UA11075A (cg-RX-API-DMAC7.html)
YU (1) YU197387A (cg-RX-API-DMAC7.html)
ZA (1) ZA878183B (cg-RX-API-DMAC7.html)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0334083B1 (de) * 1988-03-19 1991-07-24 ASTA Pharma Aktiengesellschaft Ifosfamid-Mesna-Lyophilisat und Verfahren zu dessen Herstellung
US5227373A (en) * 1991-10-23 1993-07-13 Bristol-Myers Squibb Co. Lyophilized ifosfamide compositions
WO1995007083A1 (en) * 1993-09-10 1995-03-16 F.H. Faulding & Co. Limited Ifosfamide lyophilisate composition
DE19529057B4 (de) * 1995-08-08 2007-12-13 Baxter Healthcare S.A. Ifosfamid-Lyophilisat-Zubereitungen
ES2253877T3 (es) * 1998-03-03 2006-06-01 SHIONOGI & CO., LTD. Composiciones farmaceuticas que contienen el inhibidor de fosfolipasa((3-(2-amino-1,2-dioxoetil)-2-etil-1-(fenilmetil)-1h-indol-4-il)oxi)acetato de sodio.
AU2003276689B2 (en) * 2002-09-05 2009-04-09 Bharat Serums And Vaccines Ltd. Liquid stable composition of oxazaphosphorine with mesna
KR101066181B1 (ko) * 2002-12-02 2011-09-20 바라트 쎄럼스 앤드 백신스 리미티드 비경구 투여용 아이포스파마이드 조성물 및 이의 제조방법
US8436190B2 (en) * 2005-01-14 2013-05-07 Cephalon, Inc. Bendamustine pharmaceutical compositions
KR101412296B1 (ko) * 2006-09-29 2014-06-25 인파 에스. 에이. 약제학적 조성물용 포장 시스템과 정맥 투여용 키트
CN105900385B (zh) * 2014-12-04 2019-08-27 华为技术有限公司 在数据通信网中的负载分配

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3732340A (en) * 1966-07-11 1973-05-08 Asta Werke Ag Chem Fab N',o-propylene phosphoric acid ester diamides
DE2750207A1 (de) * 1977-05-09 1978-11-16 Walton J Smith Gefriergetrocknete zusammensetzungen, insbesondere gefriergetrocknete pharmazeutische praeparate und verfahren zu deren herstellung
DE3279834D1 (en) * 1981-12-31 1989-08-31 Asta Pharma Ag 4-sulfido-oxaza phosphorines and their use in the treatment of cancer, and in immunosuppression
US4537883A (en) * 1982-11-12 1985-08-27 Mead Johnson & Company Lyophilized cyclophosphamide

Also Published As

Publication number Publication date
EP0265812A1 (de) 1988-05-04
CA1314231C (en) 1993-03-09
GEP19971025B (en) 1997-04-06
GR3000708T3 (en) 1991-10-10
IN168119B (cg-RX-API-DMAC7.html) 1991-02-09
PT86032B (pt) 1990-08-31
ES2017982B3 (es) 1991-03-16
DK569687D0 (da) 1987-10-30
IL84312A (en) 1991-11-21
PT86032A (de) 1987-11-01
DK169308B1 (da) 1994-10-10
HUT44932A (en) 1988-05-30
FI87140C (fi) 1992-12-10
LV10051A (lv) 1994-05-10
LV10051B (en) 1995-06-20
FI874727L (fi) 1988-05-01
DE3764235D1 (de) 1990-09-13
ZA878183B (en) 1988-05-02
JPS63159319A (ja) 1988-07-02
HU197987B (en) 1989-07-28
DK569687A (da) 1988-05-01
RU1836079C (ru) 1993-08-23
DD262582A5 (de) 1988-12-07
FI874727A0 (fi) 1987-10-27
NO873860L (no) 1988-05-02
IL84312A0 (en) 1988-03-31
FI87140B (fi) 1992-08-31
JPH0543684B2 (cg-RX-API-DMAC7.html) 1993-07-02
NO873860D0 (no) 1987-09-15
EP0265812B1 (de) 1990-08-08
EG18333A (en) 1993-12-30
YU197387A (en) 1988-12-31
MX8958A (es) 1993-12-01
ATE55250T1 (de) 1990-08-15
AU8052987A (en) 1988-05-05
KR900003491B1 (ko) 1990-05-21
KR880004814A (ko) 1988-06-27
AU598602B2 (en) 1990-06-28

Similar Documents

Publication Publication Date Title
SE8206168D0 (sv) Preparations and process for preparation thereof
ATE96032T1 (de) Verfahren zur herstellung von aloe-erzeugnissen.
AT400296B (de) Dosierungsform zur schnellen abgabe eines wirkstoffes gefolgt von einer langsamen abgabe eines wirkstoffes
AT387800B (de) Presswalze zur behandlung bahnfoermigen gutes
FI831203A0 (fi) Foerfarande foer immobilisering av biologiska material i kondenserade polyalkyleniminpolymerer
EP0259857A3 (en) Method of assaying physiologically active substances
HUT47570A (en) Insecticides containing as active substance 3-substituated-1-/chlor-tiasole-5-il-methil/-2-nitroamin-1,3-diaza-cycloalkans and process for production of the active substances
UA11075A (uk) Спосіб одержаhhя ліофілізату
DK198785A (da) 2-amino-3-ethoxycarbonylamino-6-(p-fluor-benzylamino)-pyridin-gluconatog farmaceutiske praeparater som indeholder dette stof
IT1119976B (it) Concime biologico e procedimento per la sua preparazione
ES8507265A1 (es) Un metodo de medir un ligando biologico
IT8720483A0 (it) Per la sua esecuzione. dispositivo per l'essiccazione uniforme del legno e dispositivo
FI902333A0 (fi) Menetelmä oksoftalatsinyylietikkahapon ja sen analogien valmistamiseksi
FR2594847B1 (fr) Procede de preparation de polypeptides biologiquement actifs, polypeptides obtenus et compositions les contenant
FI875684A7 (fi) 1,1,2,2-tetrahydroperfluorialkanolien ja niiden estereiden valmistusmenetelmä.
BE887324A (fr) Procede de preparation de la relaxine humaine
FI875705A7 (fi) Hapenpoistava tuote ja menetelmä sen valmistamiseksi.
NO166139C (no) Fremgangsmaate for aa maale kjemikalieinnholdet i blekevaeskeinnen celluloseindustrien og apparatur for utfoerelse av fremgangsmaaten.
BR8802710A (pt) Eletrodo de referencia de estado solido estavel na presenca de oxigenio,processo para a sua producao e sensor de ph
IT8519296A0 (it) Derivati della idantoina, procedimento per la fabbricazione degli stessi e sostanza medicinale contenente i medesimi.
FR2280902A1 (fr) Procede de recherche et de dosage de l'enzyme creatine phosphokinase
FI890477A0 (fi) Menetelmä terapeuttisesti käyttökelpoisen 2,5-diamino-6-fluoriheksaanihapon ja sen suolojen valmistamiseksi
NO872671D0 (no) 4-benzyloksy-3-pyrrolin-2-on-1-yl-acetamid, fremstilling og anvendelse derav.
IT1217413B (it) Procedimento di dosaggio di sostanze liquide o pastose e impianto per la realizzazione di tale procedimento
HUT44018A (en) Insecticides and acaricides containing as active substance 5-amin-1-phenil-pirasole derivatives and process for production of the active substances